Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Heart Failure 2Breast Neoplasms 2Neoplasms, Second Primary 1Cardiotoxicity 1Breast Diseases 1

Interventions

Carvedilol 3sacubitril and valsartan sodium hydrate drug combination 2dapagliflozin 2pertuzumab 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1Trastuzumab 1Specimen Handling 1Secondary Prevention 1Perindopril 1Ogivri 1Metoprolol 1Exercise 1Electronic Health Records 1Echocardiography 1Carnitine 1Bisoprolol 1Adrenergic beta-Antagonists 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Failure × sacubitril and valsartan sodium hydrate drug combination × Breast × Clear all
NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Silesian Centre for Heart Diseases

Phase 4 Recruiting
600 enrolled
Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT03760588 2025-02-12

PRADAII

University Hospital, Akershus

Phase 2 Completed
138 enrolled
Breast

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡